A Complementary Role of High Throughput Sequencing and Multiparameter Cytometry for Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL):an European Research Initiative (ERIC) Study

Konference: 2014 56th ASH Annual Meeting - účast ČR

Kategorie: Maligní lymfomy a leukémie

Téma: 641. CLL: Biology and Pathophysiology, excluding Therapy: Poster

Číslo abstraktu: 1976

Autoři: Andy Rawstron, PhD; Claudia Fazi, PhD; M.D. Neus Villamor, Ph.D.; M.D. Julio Delgado, Ph.D.; Remi Letestu; M.D. Florence Cymbalista, Ph.D.; Carlos Palacio; MD Francesc Bosch, PhD; MSc. Ruth M. De Tute; Stuart Liptrot; David O'Brien, FAMLs; MUDr. Martin Špaček, Ph.D.; Johan Dobber; MD Arnon P. Kater, PhD; Peter C. Gambell; Dr. David A. Westerman, MBBS, FRACP, FRCPA; Asha Soosapilla; Stephen P. Mulligan, MBBS, PhD, FRACP, FRCPA; Dr. Gerard Lozanski; Dr. Ke Lin; Prof. Andrew R Pettitt, MRCP, PhD; Dr. Gabi Brachtl; Prof.MUDr. Alexander Egle; David W Williamson, PhD; Catherine M. Sanders, PhD; Harlan Robins, PhD; Justin Boysen; M.D. Tait D. Shanafelt; MD Curtis A. Hanson; MD Jeffrey L. Jorgensen, PhD; MD William G. Wierda, PhD; MD Constance Yuan, PhD; MD Maryalice Stetler-Stevenson, PhD; Laura Z. Rassenti, PhD; MD H. Elizabeth Broome; MD Thomas J. Kipps, PhD; Mathieu Hauwel; MUDr. Iuri Marinov, CSc.; MD Fiona E. Craig, MBBS; Josep F. Nomdedéu; M.D. Carol Moreno; Ing. Olga Stehliková; prof. MUDr. Michael Doubek, Ph.D.; prof. RNDr. Šárka Pospíšilová, Ph.D.; M.D. Karl-Anton Kreuzer; Prof. MD Michael Hallek; Peter Hillmen, M.B. ChB, Ph.D.; Prof. Dr. Emili Montserrat; M.D. Paolo Ghia, Ph.D.

Datum přednesení příspěvku: 6. 12. 2014